T 0290/10 (imidazoquinoline amines/3M) vom 21.07.2014
- Europäischer Rechtsprechungsidentifikator
- ECLI:EP:BA:2014:T029010.20140721
- Datum der Entscheidung
- 21. Juli 2014
- Aktenzeichen
- T 0290/10
- Antrag auf Überprüfung von
- -
- Anmeldenummer
- 97946484.9
- Verfahrenssprache
- Englisch
- Verteilung
- Nicht verteilt (D)
- Download
- Entscheidung auf Englisch
- Amtsblattfassungen
- Keine AB-Links gefunden
- Weitere Entscheidungen für diese Akte
- -
- Zusammenfassungen für diese Entscheidung
- -
- Bezeichnung der Anmeldung
- IMMUNE RESPONSE MODIFIER COMPOUNDS FOR TREATMENT OF TH2 MEDIATED AND RELATED DISEASES
- Name des Antragstellers
- MINNESOTA MINING AND MANUFACTURING COMPANY
- Name des Einsprechenden
- Telormedix SA
- Kammer
- 3.3.01
- Leitsatz
- -
- Relevante Rechtsnormen
- European Patent Convention Art 100(a) 1973European Patent Convention Art 100(b)European Patent Convention Art 100(b) 1973
- Schlagwörter
- Request for decision in written proceedings - refused
Submissions and documents alleged to be late filed- filed within the extended time period
Earliest priority claimed - not valid for the claims of all requests
Main request, first and second auxiliary requests: inventive step (no) - obvious application of a known drug for its known purpose
Third auxiliary request: inventive step (yes) - Orientierungssatz
- -
- Zitierende Akten
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance
with the order to maintain the patent in amended form on the basis of the following documents:
Description pages:
2, 4 to 7 and 9 to 14, filed during oral proceedings on 10 November 2009 before the opposition division, and
3, filed with letter dated 26 April 2010;
Claims:
1 to 5 according to the third auxiliary request, filed with letter dated 26 April 2010.